Cencora (COR)Chair sold ~$4.27M

~$4.27M

Approx. value · 15K sh @ $292.67

310K

Holds after · shares reported

Traded

Jul 22, 2025

Filed

Jul 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
2. May 29, 2025Insider · 1 personInsiders: 2 sales (~$867K)
3. Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
4. Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
5. Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
6. Jul 22, 2025 · this disclosureInsiderChair sold ~$4.27M of COR shares in the open market

What came next

1. Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…
2. Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
3. Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market
4. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
5. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet…
6. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
7. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10)…
8. Sep 5, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
9. Sep 15, 2025FDARecall: Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carto…
10. Sep 16, 2025InsiderChair sold ~$9.09M of COR shares in the open market
11. Sep 18, 2025InsiderCEO sold ~$1.48M of COR shares in the open market
12. Oct 1, 2025InsiderOfficer sold ~$591K of COR shares in the open market
13. Oct 9, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC […
14. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 606…
15. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
16. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
17. Oct 20, 2025InsiderCEO sold ~$1.67M of COR shares in the open market
18. Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Steven H Collis, Executive Chairman

• SEC Form 4 at Elevance Health (ELV)Mar 6, 2026
• SEC Form 4 at Cencora (COR)Sep 18, 2025
• SEC Form 4 at Cencora (COR)Aug 20, 2025
• SEC Form 4 at Cencora (COR)Jun 25, 2025
• SEC Form 4 at Cencora (COR)May 21, 2025

The full history of Steven H Collis, Executive Chairman is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cencora

• SEC Form 4Oct 5, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 144Sep 16, 2026
• SEC Form 144Sep 11, 2026
• SEC Form 144Sep 4, 2026
• SEC Form 4Sep 3, 2026

Everything OQRO holds on this company is on its COR page.